Wanda Kwan

1.8k total citations
19 papers, 861 citations indexed

About

Wanda Kwan is a scholar working on Molecular Biology, Cell Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Wanda Kwan has authored 19 papers receiving a total of 861 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 9 papers in Cell Biology and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in Wanda Kwan's work include Zebrafish Biomedical Research Applications (9 papers), Genetic Neurodegenerative Diseases (5 papers) and Epigenetics and DNA Methylation (4 papers). Wanda Kwan is often cited by papers focused on Zebrafish Biomedical Research Applications (9 papers), Genetic Neurodegenerative Diseases (5 papers) and Epigenetics and DNA Methylation (4 papers). Wanda Kwan collaborates with scholars based in United States, United Kingdom and Canada. Wanda Kwan's co-authors include Trista E. North, Mauricio Cortes, Virginie Esain, Isaura M. Frost, Paul J. Muchowski, Sarah Y. Liu, Flaviano Giorgini, Thomas Möller, Torsten O. Nielsen and Wolfram Goessling and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Wanda Kwan

19 papers receiving 855 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wanda Kwan United States 14 427 244 239 204 136 19 861
Maggie L. Kalev‐Zylinska New Zealand 15 466 1.1× 298 1.2× 176 0.7× 96 0.5× 133 1.0× 34 838
Patrick Ventura United States 11 494 1.2× 101 0.4× 233 1.0× 176 0.9× 68 0.5× 11 1.1k
Elide Mantuano Italy 18 644 1.5× 135 0.6× 161 0.7× 534 2.6× 175 1.3× 48 1.3k
Konrad Oexle Germany 20 609 1.4× 155 0.6× 77 0.3× 110 0.5× 70 0.5× 63 1.3k
Naoki Nakaya United States 16 335 0.8× 80 0.3× 141 0.6× 167 0.8× 59 0.4× 23 682
Heinrich F. Bürgers Germany 12 425 1.0× 106 0.4× 78 0.3× 75 0.4× 52 0.4× 14 1.0k
Ramiro Echeverry United States 11 222 0.5× 86 0.4× 41 0.2× 92 0.5× 91 0.7× 11 539
Gretchen Golas United States 16 345 0.8× 173 0.7× 42 0.2× 199 1.0× 21 0.2× 21 869
Courtney E. Batt United States 6 249 0.6× 80 0.3× 111 0.5× 119 0.6× 37 0.3× 10 829
Klaus-Armin Nave Germany 8 300 0.7× 68 0.3× 282 1.2× 153 0.8× 39 0.3× 9 812

Countries citing papers authored by Wanda Kwan

Since Specialization
Citations

This map shows the geographic impact of Wanda Kwan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wanda Kwan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wanda Kwan more than expected).

Fields of papers citing papers by Wanda Kwan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wanda Kwan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wanda Kwan. The network helps show where Wanda Kwan may publish in the future.

Co-authorship network of co-authors of Wanda Kwan

This figure shows the co-authorship network connecting the top 25 collaborators of Wanda Kwan. A scholar is included among the top collaborators of Wanda Kwan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wanda Kwan. Wanda Kwan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Kwan, Wanda & Trista E. North. (2017). Netting Novel Regulators of Hematopoiesis and Hematologic Malignancies in Zebrafish. Current topics in developmental biology. 124. 125–160. 17 indexed citations
2.
Illendula, Anuradha, Jolanta Grembecka, Charles Schmidt, et al.. (2017). A tool compound targeting the core binding factor Runt domain to disrupt binding to CBFβ in leukemic cells. Leukemia & lymphoma. 59(9). 2188–2200. 9 indexed citations
3.
Kwan, Wanda, Mauricio Cortes, Isaura M. Frost, et al.. (2016). The Central Nervous System Regulates Embryonic HSPC Production via Stress-Responsive Glucocorticoid Receptor Signaling. Cell stem cell. 19(3). 370–382. 40 indexed citations
4.
Cortes, Mauricio, David L. Stachura, Sarah Y. Liu, et al.. (2016). Developmental Vitamin D Availability Impacts Hematopoietic Stem Cell Production. Cell Reports. 17(2). 458–468. 94 indexed citations
5.
Esain, Virginie, Wanda Kwan, Lindsay N. Theodore, et al.. (2016). HIF1α-induced PDGFRβ signaling promotes developmental HSC production via IL-6 activation. Experimental Hematology. 46. 83–95.e6. 31 indexed citations
6.
Cortes, Mauricio, Sarah Y. Liu, Wanda Kwan, et al.. (2015). Accumulation of the Vitamin D Precursor Cholecalciferol Antagonizes Hedgehog Signaling to Impair Hemogenic Endothelium Formation. Stem Cell Reports. 5(4). 471–479. 15 indexed citations
7.
Esain, Virginie, Wanda Kwan, Kelli J. Carroll, et al.. (2015). Cannabinoid Receptor-2 Regulates Embryonic Hematopoietic Stem Cell Development via Prostaglandin E2 and P-Selectin Activity. Stem Cells. 33(8). 2596–2612. 26 indexed citations
8.
Li, Yan, Virginie Esain, Li Teng, et al.. (2014). Inflammatory signaling regulates embryonic hematopoietic stem and progenitor cell production. Genes & Development. 28(23). 2597–2612. 198 indexed citations
9.
Carroll, Kelli J., Virginie Esain, Maija Garnaas, et al.. (2014). Estrogen Defines the Dorsal-Ventral Limit of VEGF Regulation to Specify the Location of the Hemogenic Endothelial Niche. Developmental Cell. 29(4). 437–453. 36 indexed citations
10.
Carroll, Kelli J., Michael Dovey, Claire C. Cutting, et al.. (2013). 17beta-estradiol has a biphasic effect on the formation of hematopoietic stem cells. Experimental Hematology. 41(8). S12–S12. 1 indexed citations
11.
Kwan, Wanda, Anna Magnusson, Austin Chou, et al.. (2012). Bone Marrow Transplantation Confers Modest Benefits in Mouse Models of Huntington's Disease. Journal of Neuroscience. 32(1). 133–142. 60 indexed citations
12.
Kwan, Wanda, Ulrike Träger, Dimitrios Davalos, et al.. (2012). Mutant huntingtin impairs immune cell migration in Huntington disease. Journal of Clinical Investigation. 122(12). 4737–4747. 114 indexed citations
13.
Kwan, Wanda. (2011). lnvestigating the Role of Microglia and the Immune System in Huntington's Disease. 1 indexed citations
14.
Tauber, Eran, Leonor Miller‐Fleming, Robert P. Mason, et al.. (2010). Functional Gene Expression Profiling in Yeast Implicates Translational Dysfunction in Mutant Huntingtin Toxicity. Journal of Biological Chemistry. 286(1). 410–419. 42 indexed citations
15.
Liu, Shuzhen, Hongwei Cheng, Wanda Kwan, Joanna M. Lubieniecka, & Torsten O. Nielsen. (2008). Histone deacetylase inhibitors induce growth arrest, apoptosis, and differentiation in clear cell sarcoma models. Molecular Cancer Therapeutics. 7(6). 1751–1761. 49 indexed citations
16.
Giorgini, Flaviano, Thomas Möller, Wanda Kwan, et al.. (2007). Histone Deacetylase Inhibition Modulates Kynurenine Pathway Activation in Yeast, Microglia, and Mice Expressing a Mutant Huntingtin Fragment. Journal of Biological Chemistry. 283(12). 7390–7400. 80 indexed citations
17.
Lubieniecka, Joanna M., Wanda Kwan, Jefferson Terry, & Torsten O. Nielsen. (2005). Growth inhibition of synovial sarcoma cells by curcumin. Cancer Research. 65. 152–153. 1 indexed citations
18.
Terry, Jefferson, et al.. (2005). Hsp90 Inhibitor 17-Allylamino-17-Demethoxygeldanamycin Prevents Synovial Sarcoma Proliferation via Apoptosis in In vitro Models. Clinical Cancer Research. 11(15). 5631–5638. 40 indexed citations
19.
Kwan, Wanda, et al.. (2005). Effect of depsipeptide (NSC 630176), a histone deacetylase inhibitor, on human synovial sarcoma in vitro. Journal of Clinical Oncology. 23(16_suppl). 9039–9039. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026